Última actualización: Agosto 17, 2026
Registro de ensayos clínicos multicéntricos internacionales de medicamentos en Rusia
Lista de estudios: Estudiar 1: Título: A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy Recruitment: Recruiting Study Results: No Results Available Conditions: Cáncer|Catarata|Baja densidad mineral ósea|osteopenia|Osteoporosis|Prostate Cancer Interventions: Biológico: Denosumab|Biológico: Placebo URL: http://ClinicalTrials.gov/show/NCT00925600 Study 2: Título: Moxifloxacin in Pediatric Subjects With Complicated Intra-abdominal Infection Recruitment: Recruiting Study Results: No Results Available Conditions: Intra-Abdominal Infection Interventions: Droga: moxifloxacina (Avelox, BAY12-8039)|Droga: Ertapenem, Amoxicillin/clavulanate URL: http://ClinicalTrials.gov/show/NCT01069900 Study 3: Título: A Study of LY2140023 in Patients With Schizophrenia Recruitment: Recruiting Study Results: No Results Available Conditions: Schizophrenia Interventions: Droga: LY2140023|Droga: Placebo URL: http://ClinicalTrials.gov/show/NCT01307800 Study 4: Título: Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism Recruitment: Recruiting Study Results: No Results Available Conditions: Venous Thrombosis Interventions: Droga: enoxaparina|Droga: warfarina|Droga: Placebo para apixabán|Droga: Placebo para enoxaparina|Droga: Placebo para warfarina|Droga: apixaban URL: http://ClinicalTrials.gov/show/NCT00643201 Study 5: Título: Lógica - Estudio de optimización de lapatinib en ErbB2 (HER2) Cáncer gástrico positivo: Una Fase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib Recruitment: Recruiting Study Results: No Results Available Conditions: o adenocarcinoma de la unión gastroesofágica que es irresecable debido a metástasis localmente avanzada, o Enfermedad localmente recurrente.|ErbB2 (HER2) Gástrico amplificado|Neoplasias, Tracto gastrointestinal|Esophageal Interventions: Droga: lapatinib|Droga: Placebo URL: http://ClinicalTrials.gov/show/NCT00680901 Study 6: Título: Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Cáncer de mama avanzado|Breast Cancer Interventions: Droga: neratinib|Droga: lapatinib|Droga: Capecitabine URL: http://ClinicalTrials.gov/show/NCT00777101 Study 7: Título: Una etiqueta abierta, Aleatorizado, Estudio multicéntrico de fase IIIb para evaluar la eficacia, Safety and Tolerance of BERIPLEX® P/N Compared With Plasma for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Subjects Requiring an Urgent Surgical or Urgent Invasive Procedure Recruitment: Recruiting Study Results: No Results Available Conditions: Reversal of Coagulopathy Interventions: Biológico: Beriplex®N/P|Biológico: Fresh frozen plasma URL: http://ClinicalTrials.gov/show/NCT00803101 Study 8: Título: Efficacy and Safety of Daclizumab High Yield Process Versus Interferon β 1a in Patients With Relapsing-Remitting Multiple Sclerosis Recruitment: Recruiting Study Results: No Results Available Conditions: Relapsing Remitting Multiple Sclerosis Interventions: Droga: Interferón b 1a|Droga: DAC HYP URL: http://ClinicalTrials.gov/show/NCT01064401 Study 9: Título: IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell Carcinoma Recruitment: Recruiting Study Results: No Results Available Conditions: Metastatic Renal Cell Carcinoma Interventions: Droga: sunitinib|Biológico: IMA901 más GM-CSF|Droga: Cyclophosphamide URL: http://ClinicalTrials.gov/show/NCT01265901 Study 10: Título: A Study to Observe Real-life Allocation of Antipsychotics in Acute Inpatient Management of Schizophrenia Recruitment: Recruiting Study Results: No Results Available Conditions: Schizophrenia Interventions: URL: http://ClinicalTrials.gov/show/NCT01394601 Study 11: Título: Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function Recruitment: Recruiting Study Results: No Results Available Conditions: Enfermedades cardiovasculares|Enfermedades del corazón|Insuficiencia cardiaca, Congestive Interventions: Droga: Antagonista de la aldosterona (espironolactona)|Droga: Placebo URL: http://ClinicalTrials.gov/show/NCT00094302 Study 12: Título: Una fase 3 Estudio de brentuximab vedotina (SGN-35) en pacientes con alto riesgo de linfoma de Hodgkin residual después de un trasplante de células madre (El ensayo AETHERA) Reclutamiento: Recruiting Study Results: No Results Available Conditions: Enfermedad, Hodgkin Interventions: Droga: brentuximab vedotina|Droga: placebo URL: http://ClinicalTrials.gov/show/NCT01100502 Study 13: Título: Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures Recruitment: Recruiting Study Results: No Results Available Conditions: Convulsiones|Epilepsia|Partial-Onset Seizures Interventions: Droga: Retigabine IR URL: http://ClinicalTrials.gov/show/NCT01227902 Study 14: Título: A Rheumatoid Arthritis Study in Patients on a Background Treatment of Methotrexate Recruitment: Recruiting Study Results: No Results Available Conditions: Rheumatoid Arthritis Interventions: Droga: LY2127399|Droga: Placebo every 2 semanas|Droga: Placebo every 4 weeks URL: http://ClinicalTrials.gov/show/NCT01198002 Study 15: Título: Study of Eniluracil + 5-Fluorouracil (5-fu) + Leucovorin Versus Capecitabine in Metastatic Breast Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Metastatic Breast Cancer Interventions: Droga: Eniluracil|Droga: 5-Fluorouracil|Droga: Leucovorin|Droga: Capecitabine URL: http://ClinicalTrials.gov/show/NCT01231802 Study 16: Título: A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine Recruitment: Recruiting Study Results: No Results Available Conditions: Tumor|Pain Interventions: Droga: CG5503 ER|Droga: Placebo to match CG5503|Droga: Morphine Sulphate CR|Droga: Placebo to match Morphine Sulphate CR URL: http://ClinicalTrials.gov/show/NCT00472303 Study 17: Título: Study Evaluating Long-Term Safety Of ATN-103 In Subjects With Rheumatoid Arthritis Recruitment: Recruiting Study Results: No Results Available Conditions: Rheumatoid Arthritis Interventions: Droga: ATN-103|Droga: ATN-103 URL: http://ClinicalTrials.gov/show/NCT01063803 Study 18: Título: A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia Recruitment: Recruiting Study Results: No Results Available Conditions: Lymphocytic Leukemia, Chronic Interventions: Droga: rituximab [MabThera]|Droga: rituximab [MabThera]|Droga: rituximab [MabThera]|Droga: Fludarabine|Droga: Cyclophosphamide URL: http://ClinicalTrials.gov/show/NCT01292603 Study 19: Título: A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection Recruitment: Recruiting Study Results: No Results Available Conditions: Chronic Hepatitis B Virus, Pediatric Interventions: Droga: Entecavir|Droga: Placebo URL: http://ClinicalTrials.gov/show/NCT01079806 Study 20: Título: Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia Recruitment: Recruiting Study Results: No Results Available Conditions: Alopecia|Androgenetic Alopecia Interventions: Droga: 1mg Finasteride active|Droga: 0.02mg dutasteride|Droga: 0.1mg dutasteride|Droga: 0.5mg dutasteride|Droga: Finasteride placebo|Droga: Dutasteride placebo URL: http://ClinicalTrials.gov/show/NCT01231607 Study 21: Título: Catheter Ablation Versus Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial Recruitment: Recruiting Study Results: No Results Available Conditions: Fibrilación auricular|Arritmia|Stroke Prevention|Mortality Interventions: Device: Left atrial ablation|Droga: Rate or Rhythm Control Therapy URL: http://ClinicalTrials.gov/show/NCT00911508 Study 22: Título: Estudio de resultados cardiovasculares de alogliptina en sujetos con tipo 2 Diabetes and Acute Coronary Syndrome Recruitment: Recruiting Study Results: No Results Available Conditions: Diabetes mellitus, Tipo 2|Acute Coronary Syndrome Interventions: Droga: Alogliptina|Droga: Placebo URL: http://ClinicalTrials.gov/show/NCT00968708 Study 23: Título: Evaluation of Tiotropium 2.5 y 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I Recruitment: Recruiting Study Results: No Results Available Conditions: Asthma Interventions: Droga: Placebo|Droga: Placebo|Droga: Placebo|Droga: Placebo|Droga: Placebo|Droga: 50 mcg de salmeterol HFA MDI|Droga: 5 mcg de tiotropio Respimat®|Droga: 2.5 mcg tiotropium Respimat® URL: http://ClinicalTrials.gov/show/NCT01172808 Study 24: Título: Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma Recruitment: Recruiting Study Results: No Results Available Conditions: Hepatocellular Carcinoma Interventions: Droga: sorafenib|Biológico: mapatumumab URL: http://ClinicalTrials.gov/show/NCT01258608 Study 25: Título: Estudio de letrozol con o sin EP 0332991 For The First-Line Treatment Of Hormone-Receptor Positive Advanced Breast Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Breast Cancer Interventions: Droga: PD 0332991|Droga: letrozol|Droga: letrozole URL: http://ClinicalTrials.gov/show/NCT00721409 Study 26: Título: Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Plus Paclitaxel and Carboplatin Versus Placebo Plus Paclitaxel and Carboplatin Recruitment: Recruiting Study Results: No Results Available Conditions: Cáncer de pulmón - Non Small Cell Interventions: Droga: ipilimumab|Droga: Placebo|Droga: Paclitaxel|Droga: Carboplatin URL: http://ClinicalTrials.gov/show/NCT01285609 Study 27: Título: Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients Recruitment: Recruiting Study Results: No Results Available Conditions: Alzheimer Disease Interventions: Droga: bapineuzumab|Droga: bapineuzumab|Droga: placebo URL: http://ClinicalTrials.gov/show/NCT00667810 Study 28: Título: Estudio de la eficacia & Seguridad de lenalidomida frente a clorambucilo como tratamiento de primera línea para pacientes de edad avanzada con LLC de células B (El ensayo ORIGEN) Reclutamiento: Recruiting Study Results: No Results Available Conditions: Leucemia linfocítica crónica de células B (LLC B) Intervenciones: Droga: Lenalidomida|Droga: Chlorambucil URL: http://ClinicalTrials.gov/show/NCT00910910 Study 29: Título: Un estudio de MabThera (Rituximab) in Combination With Fludarabine and Cyclophosphamide in Patients With Chronic Lymphocytic Leukemia And Favorable Somatic Status Recruitment: Recruiting Study Results: No Results Available Conditions: Lymphocytic Leukemia, Chronic Interventions: Droga: rituximab [MabThera]|Droga: fludarabina|Droga: cyclophosphamide URL: http://ClinicalTrials.gov/show/NCT01271010 Study 30: Título: A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Neoplasias, Breast Interventions: Droga: lapatinib|Droga: trastuzumab|Droga: Aromatase inhibitor|Droga: lapatinib URL: http://ClinicalTrials.gov/show/NCT01160211 Study 31: Título: A Long-Term, Placebo-Controlled X-Ray Study Investigating the Safety and Efficacy of SD-6010 in Subjects With Osteoarthritis of the Knee Recruitment: Recruiting Study Results: No Results Available Conditions: Osteoarthritis Interventions: Droga: SD-6010|Droga: SD-6010|Droga: Placebo URL: http://ClinicalTrials.gov/show/NCT00565812 Study 32: Título: Study on BI 54903 (Inhaled Corticosteroid) Administered Once Daily or Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Low Dose Inhaled Corticosteroids Recruitment: Not yet recruiting Study Results: No Results Available Conditions: Asthma Interventions: Droga: Placebo matching Respimat|Droga: Placebo matching Respimat|Droga: BI 54903 Maryland|Droga: BI 54903 HD URL: http://ClinicalTrials.gov/show/NCT01458912 Study 33: Título: Study to Evaluate the Safety and Efficacy of IV Infusion Treatment With Omecamtiv Mecarbil in Subjects With Left Ventricular Systolic Dysfunction Hospitalized for Acute Heart Failure Recruitment: Recruiting Study Results: No Results Available Conditions: Heart Failure Interventions: Droga: Placebo|Droga: Omecamtiv mecarbil URL: http://ClinicalTrials.gov/show/NCT01300013 Study 34: Título: Study of Immunotherapy to Treat Advanced Prostate Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Prostate Cancer Interventions: Droga: ipilimumab|Droga: Placebo URL: http://ClinicalTrials.gov/show/NCT00861614 Study 35: Título: Fase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin Recruitment: Recruiting Study Results: No Results Available Conditions: Non-small Cell Lung Cancer Interventions: Droga: Tavocept(BNP7787) in combination with cisplatin and either docetaxel or paclitaxel|Droga: Placebo in combination with cisplatin and docetaxel or paclitaxel URL: http://ClinicalTrials.gov/show/NCT00966914 Study 36: Título: An Efficacy, Seguridad, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment Recruitment: Recruiting Study Results: No Results Available Conditions: Diabetes mellitus, Tipo 2|Renal Insufficiency Interventions: Droga: Canagliflozin 100 mg|Droga: Canagliflozin 300 mg|Droga: Placebo URL: http://ClinicalTrials.gov/show/NCT01064414 Study 37: Título: ACT-293987 in Pulmonary Arterial Hypertension Recruitment: Recruiting Study Results: No Results Available Conditions: Pulmonary Arterial Hypertension Interventions: Droga: ACT-293987|Droga: Placebo URL: http://ClinicalTrials.gov/show/NCT01106014 Study 38: Título: A Study to Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis Recruitment: Recruiting Study Results: No Results Available Conditions: Rheumatoid Arthritis Interventions: Droga: tocilizumab [RoActemra/Actemra]|Droga: tocilizumab [RoActemra/Actemra]|Droga: placebo|Droga: placebo|Droga: Fármacos antirreumáticos modificadores de la enfermedad. (FAME) URL: http://ClinicalTrials.gov/show/NCT01194414 Study 39: Título: Evaluation of Long-term Safety and Effectiveness of Fostamatinib in the Treatment of Rheumatoid Arthritis (REAL ACADEMIA DE BELLAS ARTES) Reclutamiento: Recruiting Study Results: No Results Available Conditions: Rheumatoid Arthritis Interventions: Droga: Fostamatinib|Droga: Fostamatinib|Droga: Fostamatinib URL: http://ClinicalTrials.gov/show/NCT01242514 Study 40: Título: RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial Recruitment: Recruiting Study Results: No Results Available Conditions: Insuficiencia cardiaca|Anemia|Enfermedad cardiovascular|Ventricular Dysfunction|Congestive Heart Failure Interventions: Droga: Darbepoetin alfa|Droga: Placebo URL: http://ClinicalTrials.gov/show/NCT00358215 Study 41: Título: AVAPERL1 Study: A Study of Avastin (Bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small Cell Lung Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Non-Small Cell Lung Cancer Interventions: Droga: bevacizumab [descubrí]|Droga: pemetrexed|Droga: cisplatin URL: http://ClinicalTrials.gov/show/NCT00961415 Study 42: Título: Study of ACT-129968 in Adult Patients With Partly Controlled Asthma. Reclutamiento: Recruiting Study Results: No Results Available Conditions: Asthma Interventions: Droga: ACT-129968|Droga: Placebo URL: http://ClinicalTrials.gov/show/NCT01225315 Study 43: Título: A Study of Ixabepilone as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Endometrial Cancer Interventions: Droga: Ixabepilone|Droga: doxorrubicina|Droga: Paclitaxel URL: http://ClinicalTrials.gov/show/NCT00883116 Study 44: Título: Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Kidney Neoplasms Interventions: Droga: Axitinib (AG-013736)|Droga: Sorafenib URL: http://ClinicalTrials.gov/show/NCT00920816 Study 45: Título: A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults Recruitment: Recruiting Study Results: No Results Available Conditions: Infección, Human Immunodeficiency Virus Interventions: Droga: GSK1349572|Droga: Raltegravir|Droga: GSK1349572 Placebo|Droga: Raltegravir Placebo URL: http://ClinicalTrials.gov/show/NCT01231516 Study 46: Título: A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients Recruitment: Recruiting Study Results: No Results Available Conditions: Hepatitis C Interventions: Droga: PegIFN/RBV|Droga: BI 201335 URL: http://ClinicalTrials.gov/show/NCT01330316 Study 47: Título: Effect of Multiple Infusions of AIN457 on Disease Activity in Relapsing-remitting Multiple Sclerosis Recruitment: Recruiting Study Results: No Results Available Conditions: Esclerosis múltiple|Relapsing-remitting Interventions: Droga: AIN457|Droga: Placebo URL: http://ClinicalTrials.gov/show/NCT01051817 Study 48: Título: A Study of the Efficacy and Safety of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU)/Chronic Spontaneous Urticaria (CSU) Who Remain Symptomatic Despite Antihistamine Treatment (H1) Reclutamiento: Recruiting Study Results: No Results Available Conditions: Chronic Idiopathic Urticaria Interventions: Droga: omalizumab|Droga: placebo URL: http://ClinicalTrials.gov/show/NCT01287117 Study 49: Título: Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections Recruitment: Recruiting Study Results: No Results Available Conditions: Mycoses|Micosis, Invasive|Candidemia Interventions: Droga: Isavuconazole|Droga: Caspofungin|Droga: Voriconazole URL: http://ClinicalTrials.gov/show/NCT00413218 Study 50: Título: BIBF 1120 or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Ovarian Neoplasms|Peritoneal Neoplasms Interventions: Droga: BIBF 1120|Droga: Placebo URL: http://ClinicalTrials.gov/show/NCT01015118 Study 51: Título: An Immunogenicity and Pharmacokinetics (PK) Study of DAC HYP Prefilled Syringe in Relapsing Remitting Multiple Sclerosis (RRMS) Reclutamiento: Recruiting Study Results: No Results Available Conditions: Relapsing Remitting Multiple Sclerosis Interventions: Biológico: Daclizumab High Yield Process prefilled syringe URL: http://ClinicalTrials.gov/show/NCT01462318 Study 52: Título: Study in Adolescents With Schizophrenia or Bipolar Disorder Recruitment: Recruiting Study Results: No Results Available Conditions: Trastorno bipolar I|Schizophrenia Interventions: Droga: olanzapina|conductual: Standard behavioral weight intervention|conductual: Intense behavioral weight intervention URL: http://ClinicalTrials.gov/show/NCT00982020 Study 53: Título: ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation Recruitment: Recruiting Study Results: No Results Available Conditions: Coronary Artery Disease Interventions: Droga: RVX000222|Droga: Placebo RVX000222 URL: http://ClinicalTrials.gov/show/NCT01067820 Study 54: Título: Un estudio de RO4917838 en pacientes con síntomas de esquizofrenia controlados de forma subóptima (NN25307) Reclutamiento: Recruiting Study Results: No Results Available Conditions: Schizophrenia Interventions: Droga: RO4917838|Droga: RO4917838|Droga: Placebo URL: http://ClinicalTrials.gov/show/NCT01235520 Study 55: Título: Efficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Subjects With PHPT Unable to Undergo Parathyroidectomy Recruitment: Recruiting Study Results: No Results Available Conditions: Hiperparatiroidismo, Primary Interventions: Droga: cinacalcet clorhidrato|Droga: Placebo URL: http://ClinicalTrials.gov/show/NCT00975221 Study 56: Título: Evaluación de la eficacia de dos regímenes de dosificación de fostamatinib en comparación con placebo en pacientes con artritis reumatoide (REAL ACADEMIA DE BELLAS ARTES) ¿Quiénes toman metotrexato pero no responden?. Reclutamiento: Recruiting Study Results: No Results Available Conditions: Rheumatoid Arthritis Interventions: Droga: fostamatinib|Droga: fostamatinib|Droga: placebo, fostamatinib URL: http://ClinicalTrials.gov/show/NCT01197521 Study 57: Título: Estudio de seguridad a largo plazo de retigabina de liberación inmediata (Y) como terapia complementaria en el tratamiento de adultos con convulsiones de inicio parcial (punto de venta). Reclutamiento: Recruiting Study Results: No Results Available Conditions: Convulsiones|Epilepsia|Partial-Onset Seizures Interventions: Droga: Retigabine IR URL: http://ClinicalTrials.gov/show/NCT01336621 Study 58: Título: Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in ErbB2 (HER2) Positive Metastatic Breast Cancer. Reclutamiento: Recruiting Study Results: No Results Available Conditions: Cáncer de mama metastásico|Metástasis, Brain Interventions: Droga: capecitabine|Droga: lapatinib|Droga: trastuzumab URL: http://ClinicalTrials.gov/show/NCT00820222 Study 59: Título: STREAM-Strategic Reperfusion (With Tenecteplase and Antithrombotic Treatment) Early After Myocardial Infarction Recruitment: Recruiting Study Results: No Results Available Conditions: Myocardial Infarction Interventions: Droga: tenecteplase|Droga: enoxaparin|Droga: clopidogrel|Procedimiento: catheterisation|Procedimiento: primary PCI URL: http://ClinicalTrials.gov/show/NCT00623623 Study 60: Título: A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Patients With Relapsing Multiple Sclerosis Recruitment: Recruiting Study Results: No Results Available Conditions: Esclerosis múltiple, Relapsing-Remitting Interventions: Droga: ocrelizumab|Droga: Rebif|Droga: ocrelizumab placebo|Droga: Rebif placebo URL: http://ClinicalTrials.gov/show/NCT01247324 Study 61: Título: CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes Recruitment: Recruiting Study Results: No Results Available Conditions: Diabetes mellitus, Tipo 2 Intervenciones: Droga: linagliptina|Droga: glimepiride URL: http://ClinicalTrials.gov/show/NCT01243424 Study 62: Título: PANORAMA Observational Study Recruitment: Recruiting Study Results: No Results Available Conditions: Arritmia|Marcapasos cardiaco, Artificial|Desfibriladores, Implantable Interventions: Device: Marcapasos cardiaco, Desfibrilador, pacemaker lead URL: http://ClinicalTrials.gov/show/NCT00382525 Study 63: Título: GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Cáncer de pulmón de células no pequeñas con antígeno tumoral positivo|Cáncer de pulmón, Non-Small Cell Interventions: Biológico: GSK1572932A Inmunoterapéutico contra el cáncer específico de antígeno|Biológico: Placebo Control URL: http://ClinicalTrials.gov/show/NCT00480025 Study 64: Título: Un estudio de la calidad de vida y la respuesta al tratamiento con NeoRecormon una vez a la semana (Epoetina Beta) Tratamiento en pacientes anémicos con neoplasias malignas sólidas y linfoides. Reclutamiento: Recruiting Study Results: No Results Available Conditions: Anemia Interventions: Droga: epoetina beta [NeoRecormón]|Droga: epoetina beta [NeoRecormón] URL: http://ClinicalTrials.gov/show/NCT00776425 Study 65: Título: Tratamiento Innohep® a largo plazo versus un antagonista de la vitamina K (warfarina) para el tratamiento de la tromboembolia venosa (TEV) in Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Venous Thromboembolism Interventions: Droga: warfarina|Droga: Innohep® URL: http://ClinicalTrials.gov/show/NCT01130025 Study 66: Título: Combivir And Maraviroc In Antiretroviral Naive Subjects In Russia Recruitment: Recruiting Study Results: No Results Available Conditions: HIV Interventions: Droga: HIV therapy URL: http://ClinicalTrials.gov/show/NCT01275625 Study 67: Título: LUX-Mama 2; Afatinib en HER2 (Receptor del factor de crecimiento epidérmico humano)-Treatment Failures Recruitment: Recruiting Study Results: No Results Available Conditions: Breast Neoplasms Interventions: Droga: Afatinib 40 mg una vez al día (DE)|Droga: vinorelbina 25 mg/m2 semanal|Droga: Paclitaxel 80 mg/m2 weekly URL: http://ClinicalTrials.gov/show/NCT01271725 Study 68: Título: Un estudio de onartuzumab (MetMAb) en combinación con Tarceva (Erlotinib) en pacientes con cáncer de pulmón de células no pequeñas con diagnóstico positivo que han recibido quimioterapia para una enfermedad avanzada o metastásica (MetLung) Reclutamiento: Not yet recruiting Study Results: No Results Available Conditions: Non-Small Cell Lung Cancer Interventions: Droga: onartuzumab [MetMAb]|Droga: erlotinib [Tarčeva]|Droga: Placebo URL: http://ClinicalTrials.gov/show/NCT01456325 Study 69: Título: Estudio de fase III de docetaxel + Ramucirumab or Placebo in Breast Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Breast Cancer Interventions: Biológico: ramucirumab (IMC-1121B)|Droga: docetaxel|Otro: placebo URL: http://ClinicalTrials.gov/show/NCT00703326 Study 70: Título: ACT-128800 in Patients With Relapsing-remitting Multiple Sclerosis -Extension Study Recruitment: Recruiting Study Results: No Results Available Conditions: Relapsing-remitting Multiple Sclerosis Interventions: Droga: ACT-128800|Droga: ACT-128800|Droga: ACT-128800 URL: http://ClinicalTrials.gov/show/NCT01093326 Study 71: Título: Un doble ciego, Controlado con placebo, 2-year Study of Galantamine Used to Treat Patients With Mild to Moderate Alzheimer's Disease. Reclutamiento: Recruiting Study Results: No Results Available Conditions: Enfermedad de Alzheimer|Demencia, Alzheimer Type Interventions: Droga: Galantamina|Droga: Placebo URL: http://ClinicalTrials.gov/show/NCT00679627 Study 72: Título: A Study of the Safety and Efficacy of Ustekinumab in Adolescent Patients With Psoriasis (CADMUS) Reclutamiento: Recruiting Study Results: No Results Available Conditions: Psoriasis Interventions: Biológico: ustekinumab/placebo|Biológico: ustekinumab/placebo|Biológico: ustekinumab/placebo URL: http://ClinicalTrials.gov/show/NCT01090427 Study 73: Título: PEARL Schizophrenia Maintenance Recruitment: Recruiting Study Results: No Results Available Conditions: Schizophrenia Interventions: Droga: lurasidona|Droga: Matching Placebo URL: http://ClinicalTrials.gov/show/NCT01435928 Study 74: Título: Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery Recruitment: Recruiting Study Results: No Results Available Conditions: Preterm Birth Interventions: Droga: Inyección de caproato de hidroxiprogesterona, 250mg/mL|Droga: Vehicle URL: http://ClinicalTrials.gov/show/NCT01004029 Study 75: Título: Un estudio de Aleglitazar en tipografía 2 Diabetes Patients With Moderate Renal Impairment Recruitment: Recruiting Study Results: No Results Available Conditions: Diabetes mellitus, Tipo 2 Intervenciones: Droga: aleglitazar|Droga: pioglitazone URL: http://ClinicalTrials.gov/show/NCT01043029 Study 76: Título: Roflumilast en la enfermedad pulmonar obstructiva crónica (EPOC) Pacientes tratados con combinaciones fijas de agonistas β2 de acción prolongada (DOS) y glucocorticosteroide inhalado (ICS) Reclutamiento: Recruiting Study Results: No Results Available Conditions: Chronic Obstructive Pulmonary Disease Interventions: Droga: De roflumilast|Droga: Placebo URL: http://ClinicalTrials.gov/show/NCT01329029 Study 77: Título: Un estudio para investigar la eficacia y seguridad de bendamustina en comparación con bendamustina + RO5072759 (GA101) en pacientes con tratamiento refractario a rituximab, Indolent Non-Hodgkin's Lymphoma Recruitment: Recruiting Study Results: No Results Available Conditions: Non-Hodgkin's Lymphoma Interventions: Droga: debemos tener|Droga: RO5072759 URL: http://ClinicalTrials.gov/show/NCT01059630 Study 78: Título: Eficacia y seguridad de 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma Recruitment: Recruiting Study Results: No Results Available Conditions: Asthma Interventions: Droga: 2.5 mcg de tiotropio Respimat|Droga: Respimat placebo|Droga: 2.5 mcg tiotropium Respimat URL: http://ClinicalTrials.gov/show/NCT01257230 Study 79: Título: TMC125IFD3002 - El estudio del VIOLÍN: para evaluar la tolerabilidad de la etravirina, PharmacOkinetics With Other AntiretroviraLs In TreatmeNt Experienced Patients Recruitment: Recruiting Study Results: No Results Available Conditions: HIV Interventions: Droga: etravirine URL: http://ClinicalTrials.gov/show/NCT01422330 Study 80: Título: Study of Paclitaxel in Patients With Ovarian Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Cáncer de ovario epitelial|Cáncer peritoneal primario|Fallopian Tube Cancer Interventions: Droga: Pacical®|Droga: Taxol® URL: http://ClinicalTrials.gov/show/NCT00989131 Study 81: Título: Un estudio sobre la adición de Avastin (Bevacizumab) to Carboplatin and Paclitaxel Therapy in Patients With Ovarian Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Ovarian Cancer Interventions: Droga: bevacizumab [descubrí]|Droga: carboplatino|Droga: Paclitaxel URL: http://ClinicalTrials.gov/show/NCT01239732 Study 82: Título: Asthma in Children Recruitment: Recruiting Study Results: No Results Available Conditions: Asthma Interventions: URL: http://ClinicalTrials.gov/show/NCT01286532 Study 83: Título: Un estudio de MabThera (Rituximab) en pacientes con artritis reumatoide que han tenido una respuesta inadecuada a un único inhibidor anti-TNF. Reclutamiento: Recruiting Study Results: No Results Available Conditions: Rheumatoid Arthritis Interventions: Droga: rituximab [MabThera/Rituxan]|Droga: Methotrexate URL: http://ClinicalTrials.gov/show/NCT00576433 Study 84: Título: A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Patients With Relapsing Multiple Sclerosis Recruitment: Recruiting Study Results: No Results Available Conditions: Esclerosis múltiple, Relapsing-Remitting Interventions: Droga: ocrelizumab|Droga: Rebif|Droga: ocrelizumab placebo|Droga: Rebif placebo URL: http://ClinicalTrials.gov/show/NCT01412333 Study 85: Título: Estudio de carboplatino/paclitaxel en combinación con ABT-869 en sujetos con cáncer de pulmón de células no pequeñas avanzado o metastásico (NSCLC) Reclutamiento: Recruiting Study Results: No Results Available Conditions: Advanced or Metastatic Non-Small Cell Lung Cancer Interventions: Droga: ABT-869|Droga: Placebo para ABT-869|Droga: ABT-869 URL: http://ClinicalTrials.gov/show/NCT00716534 Study 86: Título: Observational Program to Assess Use of Intermittent Adjuvant Deprivation Therapy With Lucrin Depot in Patients With Advanced Prostate Cancer in Russia Recruitment: Recruiting Study Results: No Results Available Conditions: Prostate Cancer Interventions: URL: http://ClinicalTrials.gov/show/NCT01320735 Study 87: Título: A Study of the Safety and Efficacy of CNTO 328 in Combination With Best Supportive Care Compared to Best Supportive Care in Patients With Multicentric Castleman's Disease Recruitment: Recruiting Study Results: No Results Available Conditions: Castleman's Disease Interventions: Otro: Placebo|Droga: CNTO 328 URL: http://ClinicalTrials.gov/show/NCT01024036 Study 88: Título: Evaluation of SAR153191(REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients Recruitment: Recruiting Study Results: No Results Available Conditions: Rheumatoid Arthritis Interventions: Droga: SAR153191 (REGN88)|Droga: placebo URL: http://ClinicalTrials.gov/show/NCT01061736 Study 89: Título: A Study Looking at Diabetes in Kidney Transplant Recipients Receiving Immunosuppressive Regimen With or Without Steroids Recruitment: Recruiting Study Results: No Results Available Conditions: Kidney Transplantation Interventions: Droga: Advagraf|Droga: Mycophenolate Mofetil|Droga: simular|Droga: Corticosteroids URL: http://ClinicalTrials.gov/show/NCT01304836 Study 90: Título: Estudio de la combinación de Rituximab., ciclofosfamida, doxorrubicina, VELCADE, y prednisona o rituximab, ciclofosfamida, doxorrubicina, vincristina, and Prednisone in Patients With Newly Diagnosed Mantle Cell Lymphoma Recruitment: Recruiting Study Results: No Results Available Conditions: Mantle Cell Lymphoma Interventions: Droga: Rituximab, ciclofosfamida, doxorrubicina, VELCADE, y prednisona|Droga: Rituximab, ciclofosfamida, doxorrubicina, Vincristine and Prednisone URL: http://ClinicalTrials.gov/show/NCT00722137 Study 91: Título: Un doble ciego, Randomized Controlled Study in CD20-positive Diffuse B Cell Non-Hodgkin's Lymphoma Subjects Recruitment: Recruiting Study Results: No Results Available Conditions: DLBCL Interventions: Biológico: TL011|Biológico: Rituximab URL: http://ClinicalTrials.gov/show/NCT01205737 Study 92: Título: Phase III Trial Comparing Capecitabine in Combination With Sorafenib or Placebo in the Treatment of Locally Advanced or Metastatic HER2-Negative Breast Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Breast Cancer Interventions: Droga: sorafenib(nexavar, BAY43-9006) / capecitabina|Droga: Placebo / Capecitabine URL: http://ClinicalTrials.gov/show/NCT01234337 Study 93: Título: Un estudio de RoActemra/Actemra (tocilizumab) in Comparison to Etanercept in Patients With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors Recruitment: Recruiting Study Results: No Results Available Conditions: Enfermedad cardiovascular, Rheumatoid Arthritis Interventions: Droga: tocilizumab [RoActemra/Actemra]|Droga: etanercept URL: http://ClinicalTrials.gov/show/NCT01331837 Study 94: Título: Pregabalin Versus Levetiracetam In Partial Seizures Recruitment: Recruiting Study Results: No Results Available Conditions: Partial Seizures Interventions: Droga: pregabalina|Droga: levetiracetam URL: http://ClinicalTrials.gov/show/NCT00537238 Study 95: Título: Un estudio de la seguridad y tolerabilidad de la pimavanserina (ACP-103) in Patients With Parkinson's Disease Psychosis Recruitment: Recruiting Study Results: No Results Available Conditions: Parkinson's Disease Psychosis Interventions: Droga: tartrato de pimavanserina (ACP-103) URL: http://ClinicalTrials.gov/show/NCT00550238 Study 96: Título: Estudio de exenatida del ensayo de reducción de eventos cardiovasculares (EXCEL): Un ensayo para evaluar los resultados cardiovasculares después del tratamiento con exenatida una vez a la semana en pacientes con tipo 2 Diabetes Mellitus Recruitment: Recruiting Study Results: No Results Available Conditions: Tipo 2 Diabetes Mellitus Interventions: Droga: Exenatida una vez por semana|Droga: Placebo URL: http://ClinicalTrials.gov/show/NCT01144338 Study 97: Título: A Study of LY2127399 in Patients With Systemic Lupus Erythematosus Recruitment: Recruiting Study Results: No Results Available Conditions: Lupus eritematoso sistémico|Enfermedad del tejido conectivo|Autoimmune Disease Interventions: Droga: LY2127399|Droga: Placebo every 2 semanas|Droga: Placebo every 4 weeks URL: http://ClinicalTrials.gov/show/NCT01205438 Study 98: Título: Study of FP-1039 in Subjects With Endometrial Cancers Recruitment: Recruiting Study Results: No Results Available Conditions: Endometrial Cancers With FGFR2 Mutations Interventions: Droga: FP-1039 URL: http://ClinicalTrials.gov/show/NCT01244438 Study 99: Título: TMC435HPC3007 - Ensayo de fase III de TMC435 en genotipo 1 Hepatitis C-infected Patients Who Relapsed After Previous Therapy Recruitment: Recruiting Study Results: No Results Available Conditions: Hepatitis C Interventions: Droga: TMC435|Droga: Placebo URL: http://ClinicalTrials.gov/show/NCT01281839 Study 100: Título: Study of CS-7017 in Colorectal Cancer Patients Who Have Achieved Disease Control Following First-Line Chemotherapy Recruitment: Recruiting Study Results: No Results Available Conditions: Colorectal Cancer Interventions: Droga: CS-7017|Droga: Placebo URL: http://ClinicalTrials.gov/show/NCT00986440
Revisión de casos científicos
¿Le gustaría saber si los programas clínicos actuales, desarrollos recientes de investigación, o enfoques emergentes pueden ser relevante para su situación individual?
Envía tu pregunta a nuestro equipo científico. La oficina central de NBScience en el Reino Unido coordina consultas a través de la red internacional de centros médicos, científicos, y consultores especializados.
- Revisión de la información que proporcionas.
- Información relevante sobre programas clínicos y de investigación.
- Una respuesta clara y centrada en tu situación.
¿Qué pasa después??
Envía tu pregunta, recibir una revisión científica enfocada, y obtenga una respuesta clara sobre la investigación y los programas clínicos relevantes para su situación.
Su revisión científica será preparada por Dr. Helen Mélnik,Doctor en Filosofía , quien tiene más de 25 años de experiencia en investigación de células madre y programas clínicos internacionales.
Sin compromiso. Su pregunta será revisada de forma confidencial..
Información educativa y de investigación únicamente.. Este servicio no constituye consejo médico, diagnóstico, prescripción, o un personalizado recomendación de tratamiento.
